Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J.
Cbr Laboratories, Inc., Boston, MA, United States
Search 3 grants from Robert Mandle
Search grants from Cbr Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of Liver Regeneration After Acetaminophen-Induced Acute Liver Failure
Cervical T Cell Immunity to C. trachomatis
Growth Hormone Suppression in Healthy Children
Training Program in Burns, Trauma and Critical Care
Mechanisms of Myeloid Maturation Arrest in Burn Sepsis
Recently added grants:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
Preoperative Image Updating for Guidance during Brain Tumor Resection
Epigenetic Mechanisms Driving Synovial Sarcomagenesis
Understanding Long Tail Driver Mutations in Cancer
Investigating the role of KLF5 genomic alterations in tumorigenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052290-03
Application #
2229597
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (18))
Project Start
1993-08-10
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cbr Laboratories, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1996
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
NIH 1995
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
Comments
Be the first to comment on Robert Mandle's grant